Variation in ovarian conservation in women undergoing hysterectomy for benign indications

Obstetrics and Gynecology

Volumn 121, Issue 4, 2013, Pages 717-726

  Perera, Hemashi K ^c   Ananth, Cande V ^c   Richards, Catherine A ^c   Neugut, Alfred I ^c   Lewin, Sharyn N ^c   Lu, Yu Shiang ^c   Herzog, Thomas J ^c   Hershman, Dawn L ^c   Wright, Jason D ^a,b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b Columbia University ^*  (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; BENIGN UTERUS TUMOR; BLEEDING; ENDOMETRIOSIS; FEMALE; HUMAN; HYSTERECTOMY; LEIOMYOMA; MAJOR CLINICAL STUDY; MARRIED WOMAN; OUTCOME ASSESSMENT; OVARIAN PRESERVATION; OVARIECTOMY; OVARY TUMOR; PELVIC ORGAN PROLAPSE; PRIORITY JOURNAL; RACE DIFFERENCE; TREATMENT INDICATION; VAGINAL HYSTERECTOMY;

ADULT; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; OVARIECTOMY; OVARY; UTERINE DISEASES;

EID: 84876239064     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3182887a47     Document Type: Article

References (36)

1. Jacoby VL, Vittinghoff E, Nakagawa S, Jackson R, Richter HE, Chan J, et al. Factors associated with undergoing bilateral salpingo-oophorectomy at the time of hysterectomy for benign conditions. Obstet Gynecol 2009; 113: 1259-67.
2. Whiteman MK, Hillis SD, Jamieson DJ, Morrow B, Podgornik MN, Brett KM, et al. Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol 2008; 198: 34 e1-7.
3. Wu JM, Wechter ME, Geller EJ, Nguyen TV, Visco AG. Hysterectomy rates in the United States, 2003. Obstet Gynecol 2007; 110: 1091-5.
4. Jacoby VL, Autry A, Jacobson G, Domush R, Nakagawa S, Jacoby A. Nationwide use of laparoscopic hysterectomy compared with abdominal and vaginal approaches. Obstet Gynecol 2009; 114: 1041-8.
5. Baloglu A, Bezircioglu I, Cetinkaya B, Karci L, Bicer M. Development of secondary ovarian lesions after hysterectomy without oophorectomy versus unilateral oophorectomy for benign conditions: a retrospective analysis of patients during a nine-year period of observation. Clin Exp Obstet Gynecol 2010; 37: 299-302.
6. Holub Z, Jandourek M, Jabor A, Kliment L, Wagnerova M. Does hysterectomy without salpingo-oophorectomy influence the reoperation rate for adnexal pathology? A retrospective study. Clin Exp Obstet Gynecol 2000; 27: 109-12.
7. Plockinger B, Kolbl H. Development of ovarian pathology after hysterectomy without oophorectomy. J Am Coll Surg 1994; 178: 581-5.
8. Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ III. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 2006; 7: 821-8.
9. Rivera CM, Grossardt BR, Rhodes DJ, Rocca WA. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009; 16: 15-23.
10. Parker WH, Broder MS, Chang E, Feskanich D, Farquhar C, Liu Z, et al. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet Gynecol 2009; 113: 1027-37.
11. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987; 316: 1105-10.
12. Rocca WA, Grossardt BR, Geda YE, Gostout BS, Bower JH, Maraganore DM, et al. Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy. Menopause 2008; 15: 1050-9.
13. Rocca WA, Grossardt BR, Shuster LT. Oophorectomy, menopause, estrogen, and cognitive aging: the timing hypothesis. Neurodegener Dis 2010; 7: 163-6.
14. Rocca WA, Grossardt BR, Shuster LT. Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res 2011; 1379: 188-98.
15. Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 2005; 106: 219-26.
16. Berek JS, Chalas E, Edelson M, Moore DH, Burke WM, Cliby WA, et al. Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer. Obstet Gynecol 2010; 116: 733-43.
17. Prophylactic oophorectomy. Clinical management guidelines for obstetrician-gynecologists (replaces ACOG Technical Bulletin No. 111). ACOG Practice Bulletin No. 7. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1999; 67: 193-9.
18. Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Rothberg MB. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA 2010; 303: 2359-67.
19. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005; 353: 349-61.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
21. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-9.
22. Hollenbeck BK, Wei Y, Birkmeyer JD. Volume, process of care, and operative mortality for cystectomy for bladder cancer. Urology 2007; 69: 871-5.
23. Birkmeyer JD, Sun Y, Wong SL, Stukel TA. Hospital volume and late survival after cancer surgery. Ann Surg 2007; 245: 777-83.
24. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005; 162: 199-200.
25. Haymart MR, Banerjee M, Stewart AK, Koenig RJ, Birkmeyer JD, Griggs JJ. Use of radioactive iodine for thyroid cancer. JAMA 2011; 306: 721-8.
26. Merlo J, Chaix B, Ohlsson H, Beckman A, Johnell K, Hjerpe P, et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health 2006; 60: 290-7.
27. Birkmeyer NJ, Dimick JB, Share D, Hawasli A, English WJ, Genaw J, et al. Hospital complication rates with bariatric surgery in Michigan. JAMA 2010; 304: 435-42.
28. Jacoby VL, Grady D, Sawaya GF. Oophorectomy as a risk factor for coronary heart disease. Am J Obstet Gynecol 2009; 200: 140 e1-9.
29. Jacoby VL, Grady D, Wactawski-Wende J, Manson JE, Allison MA, Kuppermann M, et al. Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study. Arch Intern Med 2011; 171: 760-8.
30. Novetsky AP, Boyd LR, Curtin JP. Trends in bilateral oophorectomy at the time of hysterectomy for benign disease. Obstet Gynecol 2011; 118: 1280-6.
31. Lowder JL, Oliphant SS, Ghetti C, Burrows LJ, Meyn LA, Balk J. Prophylactic bilateral oophorectomy or removal of remaining ovary at the time of hysterectomy in the United States, 1979-2004. Am J Obstet Gynecol 2010; 202: 538 e1-9.
32. Brand AH. The RANZCOG College Statement on prophylactic oophorectomy in older women undergoing hysterectomy for benign disease: is the evidence sufficient to change practice? Aust N Z J Obstet Gynaecol 2011; 51: 296-300.
33. Plusquin C, Fastrez M, Vandromme J, Rozenberg S. Factors affecting gynaecologists' decision to perform prophylactic oophorectomy concomitantly with hysterectomy: a Belgian survey. Maturitas 2011; 70: 391-4.
34. Allison JJ, Kiefe CI, Weissman NW, Person SD, Rousculp M, Canto JG, et al. Relationship of hospital teaching status with quality of care and mortality for Medicare patients with acute MI. JAMA 2000; 284: 1256-62.
35. Joynt KE, Harris Y, Orav EJ, Jha AK. Quality of care and patient outcomes in critical access rural hospitals. JAMA 2011; 306: 45-52.
36. Werner RM, Goldman LE, Dudley RA. Comparison of change in quality of care between safety-net and non-safety-net hospitals. JAMA 2008; 299: 2180-7.